We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ingestible Drug-Delivery Materials May Improve Patient Treatment Compliance

News   Jul 26, 2017 | Original Story from MIT

 
Ingestible Drug-Delivery Materials May Improve Patient Treatment Compliance

Jinyao Liu, left, and Giovanni Traverso stretch a new hydrogel. To help ensure patients receive their full course of treatment, researchers have developed a new set of drug delivery materials made of the hydrogel. The material can reside in the stomach for up to nine days and slowly release its dosage of medication. Credit: MIT

 
 
 

RELATED ARTICLES

A Novel Epstein-Barr Virus-specific T Cell Therapy for Progressive MS

News

Mounting evidence shows that Epstein-Barr virus (EBV) plays a role in the pathology of multiple sclerosis. Consequently, an EBV-specific T Cell therapy has been developed to combat MS, and initial clinical trial results are promising.

READ MORE

Predicting Future Viral Threats to Humanity

News

Researchers have developed a model that predicts which of the viruses that can jump from animals to people can also be transmitted from person to person—and are therefore possible sources of human diseases.

READ MORE

Cutting the Legs Off Cancer

News

Melanoma skin cancer tumors grow larger and are more likely to metastasize due to interactions between a pair of molecules, according to experiments in mice and human cells. The results may restore the potential for a type of cancer therapy previously abandoned in clinical trials.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE